SJS Investment Consulting’s Collegium Pharmaceutical COLL Stock Holding History

SJS Investment Consulting’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.97K	Buy	+82	New	+$2.8K	﹤0.01%	1613

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

SJS Investment Consulting's COLL Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 82 shares worth $2.97K. The stake represents ﹤0.01% of the portfolio and ranks #1613 among its holdings.

101 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

SJS Investment Consulting held 82 shares of Collegium Pharmaceutical worth $2.97K as of Q2 2026.
Collegium Pharmaceutical was a new SJS Investment Consulting position in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1613 holding.
101 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.